Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PRT062607 |
| Trade Name | |
| Synonyms | P505-15|BIIB057 |
| Drug Descriptions |
PRT062607 is a selective inhibitor of SYK, which may lead to decreased tumor cell growth and increased sensitivity to chemotherapeutics (PMID: 23220742, PMID: 27406873). |
| DrugClasses | SYK Inhibitor 15 |
| CAS Registry Number | 1370261-96-3 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| A-770041 + PRT062607 | A-770041 PRT062607 | 0 | 0 |
| Crenolanib + PRT062607 | Crenolanib PRT062607 | 1 | 0 |
| Dasatinib + PRT062607 | Dasatinib PRT062607 | 0 | 0 |
| Gilteritinib + PRT062607 | Gilteritinib PRT062607 | 1 | 0 |
| Midostaurin + PRT062607 | Midostaurin PRT062607 | 3 | 0 |
| PRT062607 | PRT062607 | 0 | 0 |
| PRT062607 + Quizartinib | PRT062607 Quizartinib | 2 | 0 |
| PRT062607 + Sorafenib | PRT062607 Sorafenib | 2 | 0 |